Navigation Links
Many African-Americans have a gene that prolongs life after heart failure
Date:4/20/2008

About 40 percent of African-Americans have a genetic variant that can protect them after heart failure and prolong their lives, according to research conducted at Washington University School of Medicine in St. Louis and collaborating institutions.

The genetic variant has an effect that resembles that of beta blockers, drugs widely prescribed for heart failure. The new study offers a reason why beta blockers don't appear to benefit some African-Americans.

"For several years a controversy has existed in the cardiovascular field because of conflicting reports about whether beta blockers helped African-American patients," says senior author Gerald W. Dorn II, M.D., professor of medicine, associate chairman for translational research and director of the Center for Pharmacogenomics at Washington University.

"By mimicking the effect of beta blockers, the genetic variant makes it appear as if beta blockers aren't effective in these patients," he explains. "But although beta blockers have no additional benefit in heart failure patients with the variant, they are equally effective in Caucasian and African-American patients without the variant."

Co-author Stephen B. Liggett, M.D., professor of medicine and physiology at the University of Maryland School of Medicine and director of its cardiopulmonary genomics program says the discovery adds to the accumulating evidence that genetic differences contribute to the way people respond to medications and should encourage the use of genetic testing in clinical trials to identify people who can benefit from therapy tailored to their genetic makeup.

About 5 million people in the United States have heart failure, and it results in about 300,000 deaths each year. Beta blockers slow heart rate and lower blood pressure to decrease the heart's workload and prevent lethal cardiac arrhythmias.

While Caucasians with heart failure participating in clinical studies of beta blockers ha
'/>"/>

Contact: Gwen Ericson
ericsong@wustl.edu
314-286-0141
Washington University School of Medicine
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. New genetic variant associated with prostate cancer in African-Americans
2. Breast cancers behave differently before and after the age of 70
3. Can micro-scaffolding help stem cells rebuild the brain after stroke?
4. Scientists ask whether microscaffolding can help stem cells rebuild brain after stroke damage
5. Fewer babies born after Caesarean delivery
6. Cigarette after Valentine snuggle deadlier for some
7. After more than 100 years apart, webworms devastate New Zealand parsnips
8. Twinkle after-effect can help retinal patients detect vision loss quickly and cheaply
9. After drought, ponds keep up with the Joneses
10. Expecting an afternoon nap can reduce blood pressure
11. Simulation reveals how body repairs balance after damage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2015)... RALEIGH, N.C. , June 23, 2015 /PRNewswire/ ... technology, today announced the results of a recent ... unmatched accuracy on the wrist during activity. In ... biometric technology was compared along with the Apple ... for accurately measuring heart rate during activity. The ...
(Date:6/18/2015)... OXFORD, Conn. , June 18, 2015 NXT-ID, ... biometric authentication company focused on the growing mobile commerce market ... of a featured segment on "Money on the Mark", scheduled ... York City June 20 th . ... interview will be from 7:00 to 8:00pm EST. NXT-ID, Inc.,s ...
(Date:6/17/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... that Xiaomi, one of the world,s largest mobile ... ® family of capacitive touchscreen solutions and ... for its latest smartphones, the Xiaomi Mi Note ... in-cell display solutions and DDICs in discrete display ...
Breaking Biology News(10 mins):Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 3
... that broadens our understanding of time perception in the ... the bumble bee, can estimate the duration of time ... of behavior, the more sophisticated ability to estimate the ... only in humans and other vertebrates. , The ...
... of Florida scientists have delivered a gene through an eggshell ... blind. , The finding, reported Tuesday (May 23) in the ... a similar treatment can be developed for an incurable form ... to the photoreceptor cells in the retinas of an avian ...
... at UT Southwestern Medical Center have identified a group ... in the embryonic stages of development, a discovery that ... , "We engineered a fruit fly so that the ... new type of malformation, completely unexpectedly," said Dr. Eric ...
Cached Biology News:UF scientists restore sight to chickens with blinding disease 2UF scientists restore sight to chickens with blinding disease 3UT Southwestern researchers find gene mutation that leads to 'broken hearts' 2
(Date:7/2/2015)... , ... July 03, 2015 , ... Cuvettes have been used in countless labs for ... to find the cuvette they needed. As expected, this was a daunting and tiring ... wrong part because they were not able to navigate the complex catalog structure. , Now ...
(Date:7/2/2015)... ... 2015 , ... Sleepless nights will become obsolete as Luzi , a ... campaign on June 23. Sound sleepers and the sleep deprived both will love Luzi ... while the integration of the Bluetooth speaker, alarm clock and ability to charge various ...
(Date:7/1/2015)... , July 1, 2015   Decision Resources ... cited advantages of Otezla are its oral administration, ... as reported by surveyed rheumatologists. Otezla was the ... the treatment of active psoriatic arthritis in ... standard of care includes conventional oral treatments including ...
(Date:7/1/2015)... HAMILTON, Bermuda , July 1, 2015 /PRNewswire/ ... biopharmaceutical company focused on the treatment of dementia, ... investor briefing on July 22 at 5:45 p.m. ... at the Alzheimer,s Association International Conference 2015 (AAIC). ... following remarks: , Dr. Lawrence ...
Breaking Biology Technology:New Cuvette E-Commerce Website Launched by FireflySci 2Luzi Smart Lamp Recently Launched Indiegogo Campaign 2Luzi Smart Lamp Recently Launched Indiegogo Campaign 3Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3
... ... premixed formulation, DEERFIELD, Ill., ... U.S. Food and Drug Administration (FDA) has approved a,new premixed ... Discovered and developed by Astellas,Vaprisol, an arginine vasopressin (AVP) receptor ...
... Halozyme Therapeutics,Inc. (Nasdaq: HALO ), a biopharmaceutical company ... it will present at three upcoming investor conferences:, ... Hyatt Regency in La,Jolla, Calif. on Monday, October 27, ... -- Oppenheimer,s 19th Annual Healthcare Conference to be held ...
... Pharmaceuticals,Inc. (Nasdaq: ARNA ) announced today that the ... on October 28, 2008 at 2:00 p.m.,Pacific Time (5:00 ... La,Jolla, California. Jack Lief, Arena,s President and Chief Executive,Officer, ... including its,clinical development and discovery programs., A live ...
Cached Biology Technology:FDA Approves Astellas' Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia 2FDA Approves Astellas' Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia 3FDA Approves Astellas' Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia 4Halozyme Therapeutics to Present at Upcoming Investor Conferences 2Arena Pharmaceuticals to Present at the BIOCOM Investor Conference 2Arena Pharmaceuticals to Present at the BIOCOM Investor Conference 3
... The Rapid-Screen cDNA Library Panels were designed ... three sets of PCRs to identify the ... is performed in a 96-well "Master Plate," ... 5,000 clones. Having identified the positive well(s) ...
... Kit, designed for use with Ciphergens ... of amyloid peptides more straightforward and ... neuroscience proteomics applications - Monitor beta-amyloid ... beta-amyloid peptide levels with disease progression ...
... new Finnigan Pocket Surveyor software provides ... existing Finnigan Surveyor HPLC Systems. The ... running the popular Windows Pocket PC ... ability to connect directly to their ...
Reported to support murine B lymphocytes, hematopoietic tissue from bone marrow, B cells stimulated with lipopolysaccharide, T lymphocytes, and a variety of hybrid cells....
Biology Products: